Paper16909005
Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M and 5 others. Neurodegener Dis, 2005. Cited by 149 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Papers, record 16909005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16909005
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Neurons | Major topic |
| Neuroprotective Agents | Major topic |
| Triterpenes | Major topic |
| Animals | |
| Astrocytes | |
| CD40 Antigens | |
| Cell Count | |
| Cell Death | |
| Female | |
| Fluorescent Antibody Technique, Indirect | |
| Glial Fibrillary Acidic Protein | |
| HSP70 Heat-Shock Proteins | |
| Longevity | |
| Mice | |
| Mice, Transgenic | |
| Motor Neurons | |
| Neuroglia | |
| Pentacyclic Triterpenes | |
| Postural Balance | |
| Psychomotor Performance | |
| Superoxide Dismutase | |
| Superoxide Dismutase-1 | |
| Survival Analysis | |
| Tumor Necrosis Factor-alpha | |
| Up-Regulation |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851749 | Traditional Chinese botanical medicines and plant-derived bioactive compounds in amyotrophic lateral sclerosis: mechanistic evidence, translational challenges, and therapeutic opportunities. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42851749 | PubMed |
| 41870813 | Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41870813 | PubMed |
| 39577370 | Efficacy and tolerability of celastrol and edaravone in the multiple-hit rat model of infantile spasms. | Epilepsy Behav | 2025 | https://conductscience.org/library/papers/39577370 | PubMed |
| 39454934 | A variant of the Hspa8 synaptic chaperone modifies disease in a SOD1G86R mouse model of amyotrophic lateral sclerosis. | Exp Neurol | 2025 | https://conductscience.org/library/papers/39454934 | PubMed |
| 38708921 | Insights on Natural Products Against Amyotrophic Lateral Sclerosis (ALS). | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/38708921 | PubMed |
| 38482725 | Celastrol Ameliorates Neuronal Mitochondrial Dysfunction Induced by Intracerebral Hemorrhage via Targeting cAMP-Activated Exchange Protein-1. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38482725 | PubMed |
| 38127187 | Molecular Chaperones as Therapeutic Target: Hallmark of Neurodegenerative Disorders. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38127187 | PubMed |
| 37818836 | Neuronal NADPH oxidase is required for neurite regeneration of Aplysia bag cell neurons. | J Neurochem | 2023 | https://conductscience.org/library/papers/37818836 | PubMed |
| 37064431 | Celastrol: A Potential Natural Lead Molecule for New Drug Design, Development and Therapy for Memory Impairment. | Drug Des Devel Ther | 2023 | https://conductscience.org/library/papers/37064431 | PubMed |
| 36714551 | Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosis. | 3 Biotech | 2023 | https://conductscience.org/library/papers/36714551 | PubMed |
| 36339550 | The therapeutic potential of triptolide and celastrol in neurological diseases. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339550 | PubMed |
| 36311198 | Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats. | Iran J Basic Med Sci | 2022 | https://conductscience.org/library/papers/36311198 | PubMed |
| 35847498 | Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35847498 | PubMed |
| 35656110 | Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets. | Aging Dis | 2022 | https://conductscience.org/library/papers/35656110 | PubMed |
| 34361850 | The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches. | Molecules | 2021 | https://conductscience.org/library/papers/34361850 | PubMed |
| 34297314 | Pterocarpus marsupium extract extends replicative lifespan in budding yeast. | Geroscience | 2021 | https://conductscience.org/library/papers/34297314 | PubMed |
| 33913406 | Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update. | Curr Neuropharmacol | 2022 | https://conductscience.org/library/papers/33913406 | PubMed |
| 33299526 | Secondary Metabolites with Antioxidant Activities for the Putative Treatment of Amyotrophic Lateral Sclerosis (ALS): "Experimental Evidences". | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33299526 | PubMed |
| 33250707 | Postnatal Antioxidant and Anti-inflammatory Treatments Prevent Early Ketamine-Induced Cortical Dysfunctions in Adult Mice. | Front Neurosci | 2020 | https://conductscience.org/library/papers/33250707 | PubMed |
| 32862144 | Celastrol Dilates and Counteracts Ethanol-Induced Constriction of Cerebral Arteries. | J Pharmacol Exp Ther | 2020 | https://conductscience.org/library/papers/32862144 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16909005
GET https://conductscience.org/api/papers/v1/16909005/cited_by?page=2